ISRCTN74743444已完成不适用
A multi-centre, randomised, double-blind, placebo controlled clinical trial examining the efficiency and safety of multi-vitamin therapy in secondary stroke preventio
niversity of Glasgow and Greater Glasgow Health Board (UK)0 个研究点目标入组 8,000 人开始时间: 2003年5月22日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 8,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients presenting to one of the participating neurologists or general physicians within 7 months of stroke (ischaemic or haemorrhagic) or transient ischemic attack (TIA) (eye or brain) are eligible for this trial.
- •In addition the patient must:
- •1. Agree to take study medications
- •2. Be geographically accessible for follow up
- •3. Provide written informed consent
排除标准
- •1. Taking folate or vitamin B6, on medical advice
- •2. Use of vitamin supplements containing B6, B12 or Folate (unless patient agrees to take study medication instead of the vitamin supplements which they usually take)
- •3. Taking Methotrexate for any reason
- •4. Pregnancy or women of child-bearing potential who are at risk of pregnancy
- •5. Limited life expectancy
研究者
相似试验
进行中（未招募）
4 期
Aspirin for the prevention of cognitive decline in the Elderly: a Neuro-Vascular Imaging Study (ENVIS-ion), a sub-study of ASPirin in Reducing Events in the Elderly (ASPREE)ACTRN12609000613202Australian National University (ANU)600
进行中（未招募）
1 期
A multi-centre, randomised, double-blind, placebo controlled, parallel group exploratory study to investigate the efficacy, safety and tolerability of AD 337 in the treatment of fibromyalgia in female subjects.FibromyalgiaEUCTR2005-005194-30-GBArakis Ltd.200
进行中（未招募）
不适用
A multi-centre, randomized, double-blind, placebo controlled, multiple-dose, 4-way cross-over study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol salts (maleate, xinafoate and acetate) in patients with persistent asthma.persistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-010589-46-FRovartis Pharma Services AG32
进行中（未招募）
不适用
A multi-centre, randomized, double-blind, placebo controlled, multiple-dose, 4-way cross-over study to evaluate the efficacy, safety, tolerability and pharmacokinetics of orally inhaled indacaterol salts (maleate, xinafoate and acetate) in patients with persistent asthmapersistent asthmaMedDRA version: 9.1Level: LLTClassification code 10003553Term: AsthmaEUCTR2009-010589-46-DEovartis Pharma Services AG32
进行中（未招募）
1 期
A randomised, double-blind, multi-centre, placebo controlled parallel group study to evaluate the efficacy and tolerability of a new Ibuprofen gel in patients with acute sports-related traumatic blunt soft tissue injury/contusion. - Project BRONSON efficacy trial.EUCTR2009-018017-40-DEReckitt Benckiser Healthcare UK Ltd